Skip to content

Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)

Heterogeneity in Association of Heart Rate and Initial Presentation of Cardiovascular Diseases Using Linked Electronic Health Records

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01947361
Enrollment
1961286
Registered
2013-09-20
Start date
2012-01-31
Completion date
2014-12-31
Last updated
2013-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm, Cardiac Arrest, Sudden Cardiac Death, Coronary Heart Disease NOS, Heart Failure, Intracerebral Haemorrhage, Ischemic Stroke, Myocardial Infarction, Peripheral Arterial Disease, Stable Angina Pectoris, Stroke, Subarachnoid Haemorrhage, Transient Ischemic Attack, Unheralded Coronary Death, Unstable Angina

Brief summary

Study of heterogeneity in associations between heart rate and the initial presentation of 12 cardiovascular diseases.

Detailed description

This study is part of the CALIBER (Cardiovascular disease research using linked bespoke studies and electronic records) programme funded over 5 years from the NIHR and Wellcome Trust. The central theme of the CALIBER research is linkage of the Myocardial Ischaemia National Audit Project (MINAP) with primary care (GPRD) and other resources. The overarching aim of CALIBER is to better understand the aetiology and prognosis of specific coronary phenotypes across a range of causal domains, particularly where electronic records provide a contribution beyond traditional studies. CALIBER has received both Ethics approval (ref 09/H0810/16) and ECC approval (ref ECC 2-06(b)/2009 CALIBER dataset).

Interventions

None listed

Sponsors

Wellcome Trust
CollaboratorOTHER
National Institute for Health Research, United Kingdom
CollaboratorOTHER_GOV
University College, London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* One year prior to study entry (up-to-standard follow-up, CPRD quality research standard). * \> 30 years old * have at least a recorded heart rate measurement during the study period

Exclusion criteria

\- Evidence of prior atherosclerotic or cardiac disease

Design outcomes

Primary

MeasureTime frameDescription
Risk of atherosclerotic disease in patients with high or low heart rateParticipants were followed until the first Coronary disease event (an expected average of 5 years)Hazard ratios will be also presenting associations between heart rate and initial presentation of different cardiovascular diseases. These associations will be also measured between different levels of heart rate and CVDs stratified by: * by sex * gender * a range of risk factors (such as physical activity, smoking status, drinking status, etc.)

Secondary

MeasureTime frameDescription
Incidence proportions and life time risk for Cardiovascular diseasesParticipants were followed until the first Coronary disease event (an expected average of 5 years)Subhazard Ratios and Cumulative Incidence estimation of the risk of 12 different cardiovascular diseases adjusted for the 4 different levels of heart rate (\<60, 60-74, 75-89, \>90), age and sex in a lifetime period

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026